Last reviewed · How we verify
NCT05372744
Affect-regulatory Characteristics of Deceptive Placebos
NA trial testing Active Placebo labelled as antidepressant in Social Anxiety in 127 participants. Completed in 31 July 2022.
31 July 2022
Quick facts
| Lead sponsor | Philipps University Marburg |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 127 |
| Start date | 25 May 2022 |
| Primary completion | 31 July 2022 |
| Estimated completion | 31 July 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Active Placebo labelled as antidepressant
Conditions studied
- Social Anxiety — all drugs for Social Anxiety →
- Depression — all drugs for Depression →
Sponsor
Philipps University Marburg
Who can join
Adults 18 to 75, any sex, with Social Anxiety or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study tries to identify whether specifically framed expectations, induced with an active placebo nasal-spray, have effects on affective regulation processes and rumination.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The influence of expectations on shame, rumination and cognitive flexibility: an experimental investigation on affect-regulatory characteristics of deceptive placebos.
Schäfer LN, Rief W. · · 2024 · PMID 39868023 · DOI 10.3389/fpsyg.2024.1502460
Verify or expand the search:
- PubMed search for NCT05372744
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Social Anxiety
Currently open trials in the same condition.
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT07259005 — Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social Anxiety · NA · recruiting
- NCT06465589 — Variations of Anonymity, Transparency, and Efficacy in Digital Health Applications · NA · active not recruiting
- NCT06409247 — iExposure Intervention for Social Anxiety · NA · active not recruiting
- NCT06564402 — Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety · NA · recruiting
Other Philipps University Marburg trials
Trials by the same sponsor.
- NCT07498803 — Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome · Phase 2 · not yet recruiting
- NCT07388004 — Group Therapy for Major Depression: Comparing Expectation-Focused and Reward-Focused Psychotherapy Approaches · NA · recruiting
- NCT07166692 — Evaluation of a Retrieval Augmented Large Language Model as a Diagnostic Copilot in Rheumatology · NA · completed
- NCT06865534 — Large Language Models to Aid Gynecological Oncology Treatment · NA · recruiting
- NCT06968897 — Neurological Development In Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05372744 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philipps University Marburg
- Last refreshed: 23 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05372744.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing